TY - JOUR
T1 - Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing
AU - Angrist, Misha
AU - Barrangou, Rodolphe
AU - Baylis, Françoise
AU - Brokowski, Carolyn
AU - Burgio, Gaetan
AU - Caplan, Arthur
AU - Chapman, Carolyn Riley
AU - Church, George M.
AU - Cook-Deegan, Robert
AU - Cwik, Bryan
AU - Doudna, Jennifer A.
AU - Evans, John H.
AU - Greely, Henry T.
AU - Hercher, Laura
AU - Hurlbut, J. Benjamin
AU - Hynes, Richard O.
AU - Ishii, Tetsuya
AU - Lee, La Tasha Hoskins
AU - Levrier, Guillaume
AU - Liu, David R.
AU - Lunshof, Jeantine E.
AU - Macintosh, Kerry Lynn
AU - Mathews, Debra J.H.
AU - Meslin, Eric M.
AU - Mills, Peter H.R.
AU - Montoliu, Lluis
AU - Musunuru, Kiran
AU - Nicol, Dianne
AU - O’Neill, Helen
AU - Qiu, Renzong
AU - Ranisch, Robert
AU - Sherkow, Jacob S.
AU - Soni, Sheetal
AU - Terry, Sharon
AU - Topol, Eric
AU - Williamson, Robert
AU - Zhang, Feng
AU - Davies, Kevin
N1 - Publisher Copyright: © Copyright 2020, Mary Ann Liebert, Inc.
PY - 2020/10/1
Y1 - 2020/10/1
N2 - In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
AB - In September 2020, a detailed report on Heritable Human Genome Editing was published. The report offers a translational pathway for the limited approval of germline editing under limited circumstances and assuming various criteria have been met. In this perspective, some three dozen experts from the fields of genome editing, medicine, bioethics, law, and related fields offer their candid reactions to the National Academies/Royal Society report, highlighting areas of support, omissions, disagreements, and priorities moving forward.
UR - http://www.scopus.com/inward/record.url?scp=85095411385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095411385&partnerID=8YFLogxK
U2 - 10.1089/crispr.2020.29106.man
DO - 10.1089/crispr.2020.29106.man
M3 - Review article
C2 - 33095048
SN - 2573-1599
VL - 3
SP - 332
EP - 349
JO - CRISPR Journal
JF - CRISPR Journal
IS - 5
ER -